Detalhe da pesquisa
1.
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
N Engl J Med
; 384(8): 705-716, 2021 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626253
2.
Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient-reported outcomes from GRIFFIN.
Am J Hematol
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38622840
3.
Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.
Cancer
; 129(14): 2179-2191, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021929
4.
Cytomegalovirus seropositivity is associated with improved responses to CD38 monoclonal antibody therapies in multiple myeloma: A single-centre retrospective study.
Br J Haematol
; 201(5): 935-939, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36846905
5.
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies.
Circ Res
; 128(11): 1780-1801, 2021 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33934609
6.
Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancer.
J Oncol Pharm Pract
; : 10781552231212926, 2023 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37990556
7.
Harm reduction in undergraduate and graduate medical education: a systematic scoping review.
BMC Med Educ
; 23(1): 986, 2023 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129846
8.
Antibody and T-cell responses by ultra-deep T-cell receptor immunosequencing after COVID-19 vaccination in patients with plasma cell dyscrasias.
Br J Haematol
; 199(4): 520-528, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041779
9.
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
Br J Haematol
; 199(3): 355-365, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111391
10.
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Blood
; 136(8): 936-945, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325490
11.
Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report.
J Oncol Pharm Pract
; 28(5): 1244-1248, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084252
12.
Evaluation of subcutaneous daratumumab injections in the ambulatory care setting.
J Oncol Pharm Pract
; 28(8): 1819-1825, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647506
13.
Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
Cancer
; 127(22): 4233-4239, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374445
14.
Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.
Cancer
; 127(11): 1816-1826, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735504
15.
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Cancer
; 127(1): 82-92, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966625
16.
The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses.
Gynecol Oncol
; 161(1): 297-303, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33454132
17.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
18.
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies.
Future Oncol
; 17(27): 3549-3560, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154392
19.
Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(5): 876-883, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31785375
20.
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 26(10): 1784-1802, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32653624